|
1
|
The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years.
|
Med Care
|
2007
|
13.29
|
|
2
|
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.
|
J Clin Epidemiol
|
2010
|
10.65
|
|
3
|
The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation.
|
J Rheumatol
|
2003
|
4.53
|
|
4
|
Do workplace health promotion (wellness) programs work?
|
J Occup Environ Med
|
2014
|
3.80
|
|
5
|
Reduced disability and mortality among aging runners: a 21-year longitudinal study.
|
Arch Intern Med
|
2008
|
3.66
|
|
6
|
The Stanford Health Assessment Questionnaire: dimensions and practical applications.
|
Health Qual Life Outcomes
|
2003
|
3.04
|
|
7
|
Lifestyle habits and compression of morbidity.
|
J Gerontol A Biol Sci Med Sci
|
2002
|
2.40
|
|
8
|
Midlife body mass index and hospitalization and mortality in older age.
|
JAMA
|
2006
|
2.36
|
|
9
|
Antigen microarray profiling of autoantibodies in rheumatoid arthritis.
|
Arthritis Rheum
|
2005
|
2.30
|
|
10
|
Aging, natural death, and the compression of morbidity. 1980.
|
Bull World Health Organ
|
2002
|
2.22
|
|
11
|
Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis.
|
JAMA
|
2007
|
2.17
|
|
12
|
Better assessment of physical function: item improvement is neglected but essential.
|
Arthritis Res Ther
|
2009
|
2.04
|
|
13
|
Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
|
J Rheumatol
|
2002
|
1.98
|
|
14
|
Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the Health Assessment Questionnaire.
|
J Rheumatol
|
2004
|
1.91
|
|
15
|
Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis.
|
Arthritis Rheum
|
2013
|
1.72
|
|
16
|
Long-term randomized controlled trials of tailored-print and small-group arthritis self-management interventions.
|
Med Care
|
2004
|
1.63
|
|
17
|
Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines.
|
Ann Rheum Dis
|
2006
|
1.62
|
|
18
|
Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998:a longitudinal study of 3035 patients.
|
Am J Med
|
2003
|
1.47
|
|
19
|
Postponed development of disability in elderly runners: a 13-year longitudinal study.
|
Arch Intern Med
|
2002
|
1.43
|
|
20
|
Cardiovascular risk profile earlier in life and Medicare costs in the last year of life.
|
Arch Intern Med
|
2005
|
1.42
|
|
21
|
Osteoarthritis, exercise, and knee replacement.
|
J Rheumatol
|
2012
|
1.41
|
|
22
|
The compression of morbidity. 1983.
|
Milbank Q
|
2005
|
1.38
|
|
23
|
Lifestyle risk factors predict disability and death in healthy aging adults.
|
Am J Med
|
2012
|
1.27
|
|
24
|
Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI).
|
Arthritis Res Ther
|
2004
|
1.27
|
|
25
|
Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study.
|
J Rheumatol
|
2007
|
1.19
|
|
26
|
Improving patient reported outcomes using item response theory and computerized adaptive testing.
|
J Rheumatol
|
2007
|
1.17
|
|
27
|
Primary knee and hip arthroplasty among nonagenarians and centenarians in the United States.
|
Arthritis Rheum
|
2007
|
1.15
|
|
28
|
Upper-extremity and mobility subdomains from the Patient-Reported Outcomes Measurement Information System (PROMIS) adult physical functioning item bank.
|
Arch Phys Med Rehabil
|
2013
|
1.09
|
|
29
|
Patient self-management in arthritis? Yes!
|
J Rheumatol
|
2003
|
1.08
|
|
30
|
Associations of changes in exercise level with subsequent disability among seniors: a 16-year longitudinal study.
|
J Gerontol A Biol Sci Med Sci
|
2006
|
1.07
|
|
31
|
Reducing disability in older age.
|
JAMA
|
2002
|
1.06
|
|
32
|
The methotrexate therapeutic response in rheumatoid arthritis.
|
J Rheumatol
|
2002
|
1.03
|
|
33
|
Long distance running and knee osteoarthritis. A prospective study.
|
Am J Prev Med
|
2008
|
1.01
|
|
34
|
Aerobic exercise and its impact on musculoskeletal pain in older adults: a 14 year prospective, longitudinal study.
|
Arthritis Res Ther
|
2005
|
1.00
|
|
35
|
Items, Instruments, Crosswalks, and PROMIS.
|
J Rheumatol
|
2009
|
0.98
|
|
36
|
Disability in rheumatoid arthritis in the era of biological treatments.
|
Ann Rheum Dis
|
2011
|
0.96
|
|
37
|
Measuring effectiveness of drugs in observational databanks: promises and perils.
|
Arthritis Res Ther
|
2004
|
0.94
|
|
38
|
Framing health messages based on anomalies in time preference.
|
Med Sci Monit
|
2005
|
0.93
|
|
39
|
Regular vigorous physical activity and disability development in healthy overweight and normal-weight seniors: a 13-year study.
|
Am J Public Health
|
2008
|
0.88
|
|
40
|
Patient perspective: choosing or developing instruments.
|
J Rheumatol
|
2011
|
0.85
|
|
41
|
A low tension between individual and societal time aspects in health improved outcomes.
|
J Clin Epidemiol
|
2006
|
0.85
|
|
42
|
A first step to assess harm and benefit in clinical trials in one scale.
|
J Clin Epidemiol
|
2009
|
0.85
|
|
43
|
Patient perspective workshop: moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomes.
|
J Rheumatol
|
2011
|
0.85
|
|
44
|
Rate of death due to leukemia/lymphoma in patients with rheumatoid arthritis.
|
Arthritis Rheum
|
2003
|
0.85
|
|
45
|
Discounting and risk characteristics in clinical decision-making.
|
Med Sci Monit
|
2006
|
0.81
|
|
46
|
New instruments for assessing disability: not quite ready for prime time.
|
Arthritis Rheum
|
2004
|
0.80
|
|
47
|
Time-related issues with application to health gains and losses.
|
J Clin Epidemiol
|
2002
|
0.79
|
|
48
|
Challenges and progress in adverse event ascertainment and reporting in clinical trials.
|
J Rheumatol
|
2005
|
0.78
|
|
49
|
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
|
J Rheumatol
|
2005
|
0.78
|
|
50
|
The potential perils of informed consent.
|
Mcgill J Med
|
2008
|
0.78
|
|
51
|
Comparative risks of non-prescription analgesics: a structured topic review and research priorities.
|
Expert Opin Drug Saf
|
2011
|
0.78
|
|
52
|
Frailty and education in the Hispanic Health and Nutrition Examination Survey.
|
J Health Care Poor Underserved
|
2002
|
0.77
|
|
53
|
Rheumatologist perceptions of sources of health care disparities in minority rheumatoid arthritis patients.
|
J Clin Rheumatol
|
2009
|
0.77
|
|
54
|
Rheumatoid arthritis: radiographic progression is getting milder.
|
J Rheumatol
|
2005
|
0.77
|
|
55
|
The irreversible component of the disability index of the health assessment questionnaire: comment on the article by Aletaha et al.
|
Arthritis Rheum
|
2007
|
0.76
|
|
56
|
Comparison of the health assessment questionnaire disability index and the short form 36 physical functioning subscale using Rasch analysis: comment on the article by Taylor and McPherson.
|
Arthritis Rheum
|
2008
|
0.76
|
|
57
|
How to ascertain drug safety in the context of benefit. Controversies and concerns.
|
J Rheumatol
|
2009
|
0.75
|
|
58
|
Science as experiment; science as observation.
|
Nat Clin Pract Rheumatol
|
2006
|
0.75
|